These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

99 related articles for article (PubMed ID: 12004492)

  • 1. Health service use costs by personality disorder following specialist and nonspecialist treatment: a comparative study.
    Chiesa M; Fonagy P; Holmes J; Drahorad C; Harrison-Hall A
    J Pers Disord; 2002 Apr; 16(2):160-73. PubMed ID: 12004492
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Health service costs and clinical gains of psychotherapy for personality disorders: a randomized controlled trial of day-hospital-based step-down treatment versus outpatient treatment at a specialist practice.
    Kvarstein EH; Arnevik E; Halsteinli V; Rø FG; Karterud S; Wilberg T
    BMC Psychiatry; 2013 Nov; 13():315. PubMed ID: 24268099
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A cost and economic evaluation of the Leeds personality disorder managed clinical network-A service and commissioning development initiative.
    Kane E; Reeder N; Keane K; Prince S
    Personal Ment Health; 2016 Aug; 10(3):169-80. PubMed ID: 26887839
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The economic burden of personality disorders in mental health care.
    Soeteman DI; Hakkaart-van Roijen L; Verheul R; Busschbach JJ
    J Clin Psychiatry; 2008 Feb; 69(2):259-65. PubMed ID: 18363454
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The costs and effectiveness of two psychosocial treatment programmes for personality disorder: a controlled study.
    Beecham J; Sleed M; Knapp M; Chiesa M; Drahorad C
    Eur Psychiatry; 2006 Mar; 21(2):102-9. PubMed ID: 16140508
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Residential versus community treatment of personality disorders: a comparative study of three treatment programs.
    Chiesa M; Fonagy P; Holmes J; Drahorad C
    Am J Psychiatry; 2004 Aug; 161(8):1463-70. PubMed ID: 15285974
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Cost implications of treatment non-completion in a forensic personality disorder service.
    Sampson CJ; James M; Huband N; Geelan S; McMurran M
    Crim Behav Ment Health; 2013 Dec; 23(5):321-35. PubMed ID: 23881873
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Service costs for severe personality disorder at a special hospital.
    Barrett B; Byford S; Seivewright H; Cooper S; Tyrer P
    Crim Behav Ment Health; 2005; 15(3):184-90. PubMed ID: 16575796
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The Maudsley long-term follow-up of child and adolescent depression: 3. Impact of comorbid conduct disorder on service use and costs in adulthood.
    Knapp M; McCrone P; Fombonne E; Beecham J; Wostear G
    Br J Psychiatry; 2002 Jan; 180():19-23. PubMed ID: 11772846
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Strengthening the status of psychotherapy for personality disorders: an integrated perspective on effects and costs.
    Bartak A; Soeteman DI; Verheul R; Busschbach JJ
    Can J Psychiatry; 2007 Dec; 52(12):803-10. PubMed ID: 18186181
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Association between alcohol and substance use disorders and psychiatric service use in patients with severe mental illness: a nationwide Danish register-based cohort study.
    Jørgensen KB; Nordentoft M; Hjorthøj C
    Psychol Med; 2018 Nov; 48(15):2592-2600. PubMed ID: 29429425
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Intensive short-term dynamic psychotherapy for DSM-IV personality disorders: a randomized controlled trial.
    Abbass A; Sheldon A; Gyra J; Kalpin A
    J Nerv Ment Dis; 2008 Mar; 196(3):211-6. PubMed ID: 18340256
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Cost-effectiveness of psychotherapy for cluster C personality disorders: a decision-analytic model in the Netherlands.
    Soeteman DI; Verheul R; Meerman AM; Ziegler U; Rossum BV; Delimon J; Rijnierse P; Thunnissen M; Busschbach JJ; Kim JJ
    J Clin Psychiatry; 2011 Jan; 72(1):51-9. PubMed ID: 21034679
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The cost-effectiveness of the dangerous and severe personality disorder programme.
    Barrett B; Tyrer P
    Crim Behav Ment Health; 2012 Jul; 22(3):202-9. PubMed ID: 22711616
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Health service utilization costs for borderline personality disorder patients treated with psychoanalytically oriented partial hospitalization versus general psychiatric care.
    Bateman A; Fonagy P
    Am J Psychiatry; 2003 Jan; 160(1):169-71. PubMed ID: 12505818
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Psychosocial impairment and treatment utilization by patients with borderline personality disorder, other personality disorders, mood and anxiety disorders, and a healthy comparison group.
    Ansell EB; Sanislow CA; McGlashan TH; Grilo CM
    Compr Psychiatry; 2007; 48(4):329-36. PubMed ID: 17560953
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Cost-effectiveness of psychotherapy for personality disorders. A systematic review on economic evaluation studies].
    Wetzelaer P; Lokkerbol J; Arntz A; van Asselt A; Evers S
    Tijdschr Psychiatr; 2016; 58(10):717-727. PubMed ID: 27779289
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Economic impact of personality disorders in UK primary care attenders.
    Rendu A; Moran P; Patel A; Knapp M; Mann A
    Br J Psychiatry; 2002 Jul; 181():62-6. PubMed ID: 12091265
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Four years comparative follow-up evaluation of community-based, step-down, and residential specialist psychodynamic programmes for personality disorders.
    Chiesa M; Cirasola A; Fonagy P
    Clin Psychol Psychother; 2017 Nov; 24(6):1331-1342. PubMed ID: 28748608
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Clinical and economic outcomes from the UK pilot psychiatric services for personality-disordered offenders.
    Fortune Z; Barrett B; Armstrong D; Coid J; Crawford M; Mudd D; Rose D; Slade M; Spence R; Tyrer P; Moran P
    Int Rev Psychiatry; 2011; 23(1):61-9. PubMed ID: 21338300
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.